Medtronic Buys PreciSense Assets
Medtronic Inc. (NYSE: MDT) has acquired substantially all the glucose monitoring assets from PreciSense AS of Denmark. No financial terms were disclosed. PreciSense has raised a small amount of VC funding from firms like Novo AS and the Danish Growth Fund.
3 June 2009•2 mins read
